LMR Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-881,340
Closed -$89.5M 1597
2025
Q4
$89.5M Buy
881,340
+838,407
+1,953% +$67.3M 0.17% 53
2025
Q3
$2.35M Buy
42,933
+6,725
+19% +$336K 0.01% 688
2025
Q2
$1.92M Buy
36,208
+30,871
+578% +$1.57M 0.01% 656
2025
Q1
$231K Sell
5,337
-72,469
-93% -$3.67M ﹤0.01% 1037
2024
Q4
$4.37M Buy
77,806
+8,394
+12% +$522K 0.04% 423
2024
Q3
$4.73M Buy
+69,412
New +$3.92M 0.04% 384
2023
Q4
Sell
-20,175
Closed -$1.32M 1035
2023
Q3
$1.38M Buy
+20,175
New +$1.71M 0.02% 443
2022
Q4
Sell
-54,587
Closed -$1.77M 1161
2022
Q3
$1.77M Buy
+54,587
New +$2.25M 0.03% 574
2022
Q2
Sell
-149,428
Closed -$10.4M 1342
2022
Q1
$10.4M Buy
149,428
+14,608
+11% +$1.07M 0.12% 179
2021
Q4
$10.5M Buy
134,820
+30,765
+30% +$2.72M 0.11% 155
2021
Q3
$9.93M Buy
+104,055
New +$11M 0.11% 152
2020
Q1
Sell
-60,750
Closed -$5.62K 308
2019
Q4
$5.62K Buy
+60,750
New +$5.34M 0.01% 76
2019
Q2
Sell
-48,852
Closed -$4.23M 481
2019
Q1
$4.23M Buy
+48,852
New +$4.16M 0.22% 68
2018
Q4
Sell
-47,702
Closed -$3.77M 378
2018
Q3
$3.77M Sell
47,702
-143,280
-75% -$9.34M 0.24% 86
2018
Q2
$11.4M Buy
+190,982
New +$10.3M 0.59% 28
2017
Q3
Sell
-80,300
Closed -$2.84M 386
2017
Q2
$2.84M Buy
+80,300
New +$2.48M 0.18% 117

Other funds holding EXAS

LMR Partners's EXAS Position: Q1 2026 in Review

LMR Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 881,340 shares — an estimated $89.5M sold.

LMR Partners first reported a position in EXAS in Q2 2017 and held it in 16 quarters. The position peaked at $89.5M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • LMR Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • LMR Partners sold 881,340 Exact Sciences shares in Q1 2026, an estimated $89.5M.
  • LMR Partners first reported a position in Exact Sciences in Q2 2017 and held it in 16 quarters.
  • LMR Partners's Exact Sciences position peaked at $89.5M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.